Applied Therapeutics Inc buy BiotechBee
Start price
24.12.23
/
50%
€2.67
Target price
31.08.25
€5.00
Performance (%)
-16.32%
End price
05.01.24
€2.23
Summary
This prediction ended on 05.01.24 with a price of €2.23. The prediction for Applied Therapeutics Inc disappointed with a performance of -16.32%. BiotechBee has a follow-up prediction for Applied Therapeutics Inc where he still thinks Applied Therapeutics Inc is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Applied Therapeutics Inc | - | - |
| iShares Core DAX® | -1.370% | -3.231% |
| iShares Nasdaq 100 | 0.172% | -3.339% |
| iShares Nikkei 225® | -0.801% | -7.859% |
| iShares S&P 500 | -0.369% | -2.979% |
According to BiotechBee what are the pros and cons of Applied Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Applied Therapeutics Inc diskutieren
In the thread Trading Applied Therapeutics Inc
Current prediction by BiotechBee for Applied Therapeutics Inc
Applied Therapeutics Inc
Start price
Target price
Perf. (%)
€5.80
18.02.24
18.02.24
€4.00
31.01.26
31.01.26
-28.66%
30.04.24
30.04.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Applied Therapeutics Inc
Applied Therapeutics Inc
Start price
Target price
Perf. (%)
€2.75
10.12.23
10.12.23
€3.50
31.03.26
31.03.26
-3.09%
24.12.23
24.12.23
Could be very worthwhile Investment >20% year